TY  - JOUR 
AU  - Muñoz, A.
AU  - Ay, C.
AU  - Grilz, E.
AU  - López, S.
AU  - Font, C.
AU  - Pachón, V.
AU  - Castellón, V.
AU  - Martínez-Marín, V.
AU  - Salgado Fernández, Mercedes
AU  - Martínez, E.
AU  - Calzas, J.
AU  - Ortega, L.
AU  - Rupérez, A.
AU  - Salas, E.
AU  - Pabinger, I.
AU  - Soria, J.M.
PY  - 2023
SN  - 1527-7755
UR  - http://hdl.handle.net/20.500.11940/20967
AB  - PURPOSE: Venous thromboembolism (VTE) is a leading cause of death among patients with cancer. The Khorana score was developed for assessing the risk of VTE in outpatients with cancer receiving chemotherapy, but its accuracy in identifying patients at...
LA  - eng
KW  - Humans
KW  - Venous Thromboembolism
KW  - Prospective Studies
KW  - Anticoagulants
KW  - Neoplasms
KW  - Risk Factors
KW  - Thrombosis
KW  - Risk Assessment
TI  - A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
DO  - 10.1200/jco.22.00255
T2  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
M2  - 2911
KW  - AS Ourense
KW  - CHUO
VL  - 41
ER  -